clinical trial · NCT04187144
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
GlaxoSmithKline·phase3·completed·n = 1,606
Urinary Tract InfectionsGepotidacinPlacebo matching nitrofurantoinNitrofurantoinPlacebo matching gepotidacin
brief summary
The study will be conducted to evaluate the therapeutic response (combined per participant microbiological and clinical response) of oral gepotidacin compared to oral nitrofurantoin for treatment of uncomplicated UTI (acute cystitis) in adolescent and adult female participants.
started
Apr 23, 2020
primary completion
Dec 1, 2022
completion
Dec 1, 2022
last updated
Jul 18, 2023
official title
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol